Genentech is the drug company that produces Rituxan(rituximab).
Before receiving Rituxan, patients should tell their healthcare provider if they:.
With this decision, Rituxan is now approved to treat four autoimmune diseases.
He wants to treat me with Rituxan plus COP or maybe Rituxan plus CHOP.
With the latest FDA decision, Rituxan now is approved to treat four autoimmune diseases.
Genentech Access Solutions is a resource for people considering Rituxan as a treatment option.
Then with Bendamustine and Rituxan for 4 months which was discontinued when I developed pneumonia.
When I began Rituxan® in January 2013,
my Desmoglein levels had jumped from 75 to 128.
In November 2014, I used the chemotherapy drug Rituxan off-label for my rare disease, Immune Thrombocytopenia(ITP).
Serious Infections: Serious infections can happen during and after treatment with Rituxan and can lead to death;
I was given a Rituxan treatment every 6 months for almost 3 years until I reached remission.
Patients should not breastfeed during treatment and for at least 6 months after the last dose of Rituxan;
Lots of questions were asked and many focused on rituximab(Rituxan®) treatments and the use of CellCept® and IVIg.
Ultimately, I decided it was worth a shot to see if Rituxan could put my rare disease in remission.
My local oncologist wishes to commence Campath
treatment next month as he feels Fludara and Rituxan treatment no longer is beneficial.
Heart Problems: Rituxan may cause chest pain and irregular heartbeats,
which may need treatment, or a patient's doctor may decide to stop treatment with Rituxan;
I have never done IVIG or Rituxan although these therapies were discussed as options had
I not finally started doing well on the meds I was on.